Human evidence record · GHRP-6
Human pharmacokinetics of GHRP-6
Human exposure and pharmacokinetics were characterized across three IV dose levels.
Quick read
Human evidence record
What this study tells us
This was a human pharmacology or physiology study. It can show what the compound does to measured biological signals, but it may not establish a meaningful clinical benefit.
Who was studied?
Healthy men
How many?
n=9
What happened?
Human exposure and pharmacokinetics were characterized across three IV dose levels.
What stops us overclaiming?
Does not establish performance, body-composition or recovery benefits.
Need help with terms such as randomized, placebo, endpoint or sample size? Open the glossary →
Key result
Human exposure and pharmacokinetics were characterized across three IV dose levels.
Study details
Study designHealthy-volunteer pharmacokinetic study
PopulationHealthy men
Sample size9
RouteIntravenous
Regimen / exposure100, 200 or 400 micrograms/kg
DurationSingle-dose
ComparatorDose groups
Primary endpoint / questionPharmacokinetics and endocrine response
Safety resultSmall study; not a lifestyle-outcome trial.
Key limitationsDoes not establish performance, body-composition or recovery benefits.
Registry / identifierPMID 23099431